Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 327)
Posted On: 03/17/2020 6:49:01 PM
Post# of 36567
Posted By: Pokey123
So when you match up the contract timeline with today’s 8K I get the following.
Today marks 2 weeks since we singled with EpiVax.
The contract says we should have selected the materials a week ago. (Task 1)
We are 1 week into the two weeks allotted to produce peptides. (Task 2)
A week from today we should be shipping our first peptide to China (First milestone)
That will begin 3 weeks of testing. Concluding 4/14. (Task 3)
Identify vaccine (Second milestone)
Small scale production, 2 weeks. (Task 4) 4/28
Animal testing 10 days (Task 5) 5/8
Human trials 2 weeks (Task 6) 5/22
Identify safe peptide (Third milestone)
Large scale manufacturing 3 weeks (Task 7) 6/12
Clinical study, 8 weeks (Task 8) 8/7
Safe vaccine commercial ready. (Last milestone)

So if you leave some wiggle room for transportation, delays, adjustments, etc. by 9/1 we should be shipping vaccines.

I think that puts us a minimum of 6 months ahead of anyone else. If what the experts are saying and hoping is true and this virus goes quiet during the warmer weather that may be too late. However, if it lingers through the summer and begins to spike again in the fall we should be first in line ready to go.


















(5)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site